ABSTRACT
Diabetic Macular Edema is a major cause of visual impairment in economically active population, being responsible for a significant impact in quality of life in the affected population, as well as high costs to the health care system. Over decades, some studies have compared treatments using Laser, Anti-VEGF and intravitreous corticosteroids, establishing protocols to reach effectives therapies. Thus, it is essential an entire understanding of available therapies to reach the goal of disease control, in an individual basis and in a collective health care system, as efficient as possible.
Subject(s)
Humans , Macular Edema/therapy , Diabetes Complications , Laser Coagulation , Vascular Endothelial Growth Factors , Tomography, Optical Coherence , Intravitreal InjectionsABSTRACT
This is a photo essay of a 20-year-old boy who presented with a subretinal cyst. The patient first presented to us with a history of decreased vision in his left eye of 2 weeks duration with a visual acuity of 20/20 in the right eye and 20/60 in the left eye.
ABSTRACT
PURPOSE: To report the choroidal neovascularization of 4 patients in central serous chorioretinopathy treated with laser treatment. CASE SUMMARY: We reported 4 patients with central serous chorioretinopathy. Three patients were treated with focal laser photocoagulation, and 1 patient with photodynamic treatment. All patients newly developed choroidal neovascularization (CNV) after treatment at the area of laser treatment. Three patients received intravitreal anti-VEGF injection and 1 patient received argon laser photocoagulation for the treatment of CNV. After the treatment, the CNV was resolved with improved visual acuity. CONCLUSIONS: Laser treatment may be efficacious tool to achieve rapid resolution in central serous chorioretinopathy until now. However, more caution at the time of treatment and close follow-up after treatment are warranted.